{"id":"https://openalex.org/W2011587234","doi":"https://doi.org/10.1592/phco.23.5.678.32198","title":"Shock\u2010Like Sensations During Venlafaxine Withdrawal","display_name":"Shock\u2010Like Sensations During Venlafaxine Withdrawal","alternate_titles":[],"publication_year":2003,"publication_date":"2003-05-01","ids":{"openalex":"https://openalex.org/W2011587234","doi":"https://doi.org/10.1592/phco.23.5.678.32198","mag":"2011587234","pmid":"https://pubmed.ncbi.nlm.nih.gov/12741444"},"language":"en","primary_location":{"id":"doi:10.1592/phco.23.5.678.32198","doi":"https://doi.org/10.1592/phco.23.5.678.32198","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.23.5.678.32198","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011587234"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109093450","display_name":"Roy R. Reeves","orcid":"https://orcid.org/0009-0008-0219-6285","observed_orcids":["https://orcid.org/0009-0008-0219-6285"]},"institutions":[{"id":"https://openalex.org/I368840534","display_name":"University of Mississippi","ror":"https://ror.org/02teq1165","country_code":"US","type":"education","lineage":["https://openalex.org/I368840534","https://openalex.org/I4210141039"]},{"id":"https://openalex.org/I4210144720","display_name":"G.V. (Sonny) Montgomery VA Medical Center","ror":"https://ror.org/040qrra89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210138636","https://openalex.org/I4210144720"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Roy R. Reeves","raw_affiliation_strings":["Department of Psychiatry, Montgomery VA Medical Center, and the School of Medicine, University of Mississippi, Jackson, Mississippi 39216, USA. roy.reeves@med.va.gov","Departments of Psychiatry","School of Medicine, University of Mississippi, Jackson, Mississippi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Montgomery VA Medical Center, and the School of Medicine, University of Mississippi, Jackson, Mississippi 39216, USA. roy.reeves@med.va.gov","institution_ids":["https://openalex.org/I368840534","https://openalex.org/I4210144720"]},{"raw_affiliation_string":"Departments of Psychiatry","institution_ids":[]},{"raw_affiliation_string":"School of Medicine, University of Mississippi, Jackson, Mississippi","institution_ids":["https://openalex.org/I368840534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051766135","display_name":"James E Mack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I368840534","display_name":"University of Mississippi","ror":"https://ror.org/02teq1165","country_code":"US","type":"education","lineage":["https://openalex.org/I368840534","https://openalex.org/I4210141039"]},{"id":"https://openalex.org/I4210144720","display_name":"G.V. (Sonny) Montgomery VA Medical Center","ror":"https://ror.org/040qrra89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210138636","https://openalex.org/I4210144720"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James E. Mack","raw_affiliation_strings":["Departments of Pharmacology, G. V. (Sonny) Montgomery VA Medical Center","School of Medicine, University of Mississippi, Jackson, Mississippi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology, G. V. (Sonny) Montgomery VA Medical Center","institution_ids":["https://openalex.org/I4210144720"]},{"raw_affiliation_string":"School of Medicine, University of Mississippi, Jackson, Mississippi","institution_ids":["https://openalex.org/I368840534"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021979823","display_name":"John J Beddingfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I368840534","display_name":"University of Mississippi","ror":"https://ror.org/02teq1165","country_code":"US","type":"education","lineage":["https://openalex.org/I368840534","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John J. Beddingfield","raw_affiliation_strings":["Departments of Psychiatry","School of Medicine, University of Mississippi, Jackson, Mississippi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Psychiatry","institution_ids":[]},{"raw_affiliation_string":"School of Medicine, University of Mississippi, Jackson, Mississippi","institution_ids":["https://openalex.org/I368840534"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109093450"],"corresponding_institution_ids":["https://openalex.org/I368840534","https://openalex.org/I4210144720"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":1.4837,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.80343447,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"23","issue":"5","first_page":"678","last_page":"681"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.6172000169754028,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.6172000169754028,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.3264000117778778,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.9599999785423279},{"id":"https://openalex.org/keywords/drug-withdrawal","display_name":"drug withdrawal","score":0.8600000143051147},{"id":"https://openalex.org/keywords/serotonin-reuptake-inhibitors","display_name":"serotonin reuptake inhibitors","score":0.8330000042915344},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.6570000052452087},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.531000018119812}],"concepts":[{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.9204319715499878},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8951754570007324},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.6308788061141968},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5766744613647461},{"id":"https://openalex.org/C2781300812","wikidata":"https://www.wikidata.org/wiki/Q178061","display_name":"Shock (circulatory)","level":2,"score":0.5402481555938721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5056929588317871},{"id":"https://openalex.org/C2776922375","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Withdrawal syndrome","level":2,"score":0.5033389925956726},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4378054440021515},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.41103169322013855},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.36514270305633545},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22327947616577148},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.20321649312973022},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.1481051743030548},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.061654508113861084},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012678","descriptor_name":"Sensation Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1592/phco.23.5.678.32198","doi":"https://doi.org/10.1592/phco.23.5.678.32198","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.23.5.678.32198","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:12741444","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12741444","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W111699375","https://openalex.org/W947657849","https://openalex.org/W1223311551","https://openalex.org/W1594090641","https://openalex.org/W1966497539","https://openalex.org/W1967621994","https://openalex.org/W1973134867","https://openalex.org/W1986043820","https://openalex.org/W1997793349","https://openalex.org/W2005538276","https://openalex.org/W2023673457","https://openalex.org/W2038826787","https://openalex.org/W2070949427","https://openalex.org/W2087625156","https://openalex.org/W2092967638","https://openalex.org/W2242959703","https://openalex.org/W2249461443","https://openalex.org/W2250088909","https://openalex.org/W2320983364","https://openalex.org/W2321032081","https://openalex.org/W2398659627","https://openalex.org/W2402630593","https://openalex.org/W2404495567","https://openalex.org/W2411523998","https://openalex.org/W2414582250","https://openalex.org/W3027372852"],"related_works":["https://openalex.org/W7206619790","https://openalex.org/W2067524987","https://openalex.org/W2070949427","https://openalex.org/W2027000409","https://openalex.org/W317672763","https://openalex.org/W2086450354","https://openalex.org/W2037469758","https://openalex.org/W111699375","https://openalex.org/W1967621994","https://openalex.org/W293449940"],"abstract_inverted_index":{"Electric":[0],"shock-like":[1,30],"sensations":[2,31,57],"may":[3,58],"occur":[4],"after":[5,50],"cessation":[6],"of":[7,24,42,53,62],"treatment":[8],"with":[9,22,40],"serotonin":[10],"selective":[11],"reuptake":[12],"inhibitors":[13],"but":[14],"are":[15],"reported":[16],"in":[17,65],"the":[18,43,54,66],"literature":[19],"only":[20],"rarely":[21],"discontinuation":[23,52],"venlafaxine.":[25],"Two":[26],"patients":[27,37],"experienced":[28],"severe":[29],"during":[32],"venlafaxine":[33],"withdrawal.":[34],"For":[35],"both":[36],"symptoms":[38],"occurred":[39],"lowering":[41],"dosage":[44],"and":[45],"persisted":[46],"for":[47],"5":[48],"days":[49],"complete":[51],"drug.":[55],"These":[56],"represent":[59],"significant":[60],"alteration":[61],"neuronal":[63],"activity":[64],"central":[67],"nervous":[68],"system.":[69]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2011587234","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
